TSE:CTX

Crescita Therapeutics Competitors

C$0.80
-0.05 (-5.88 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
C$0.78
Now: C$0.80
C$0.86
50-Day Range
C$0.71
MA: C$0.83
C$0.90
52-Week Range
C$0.43
Now: C$0.80
C$1.01
Volume19,354 shs
Average Volume28,432 shs
Market CapitalizationC$16.52 million
P/E Ratio400.00
Dividend YieldN/A
BetaN/A

Competitors

Crescita Therapeutics (TSE:CTX) Vs. SBM, PMN, COV, EMH, IGX, and QPT

Should you be buying CTX stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Crescita Therapeutics, including Sirona Biochem (SBM), ProMIS Neurosciences (PMN), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), IntelGenx Technologies (IGX), and Quest PharmaTech (QPT).

Crescita Therapeutics (TSE:CTX) and Sirona Biochem (CVE:SBM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.

Valuation and Earnings

This table compares Crescita Therapeutics and Sirona Biochem's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00
Sirona BiochemC$123,870.00661.64C$-2,959,580.00C($0.01)-27.69

Crescita Therapeutics has higher revenue and earnings than Sirona Biochem. Sirona Biochem is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Crescita Therapeutics and Sirona Biochem, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescita Therapeutics0000N/A
Sirona Biochem0000N/A

Profitability

This table compares Crescita Therapeutics and Sirona Biochem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescita TherapeuticsN/AN/AN/A
Sirona BiochemN/AN/AN/A

Summary

Crescita Therapeutics beats Sirona Biochem on 4 of the 5 factors compared between the two stocks.

Crescita Therapeutics (TSE:CTX) and ProMIS Neurosciences (TSE:PMN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.

Valuation and Earnings

This table compares Crescita Therapeutics and ProMIS Neurosciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00
ProMIS NeurosciencesC$1,787.0030,817.57C$-6,119,000.00C($0.02)-9.00

Crescita Therapeutics has higher revenue and earnings than ProMIS Neurosciences. ProMIS Neurosciences is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Crescita Therapeutics and ProMIS Neurosciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescita Therapeutics0000N/A
ProMIS Neurosciences0000N/A

Profitability

This table compares Crescita Therapeutics and ProMIS Neurosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescita TherapeuticsN/AN/AN/A
ProMIS NeurosciencesN/AN/AN/A

Summary

Crescita Therapeutics beats ProMIS Neurosciences on 4 of the 5 factors compared between the two stocks.

Crescita Therapeutics (TSE:CTX) and Covalon Technologies (CVE:COV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.

Valuation and Earnings

This table compares Crescita Therapeutics and Covalon Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00
Covalon TechnologiesC$23.84 million1.68C$-6,144,922.00C($0.24)-6.51

Crescita Therapeutics has higher earnings, but lower revenue than Covalon Technologies. Covalon Technologies is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Crescita Therapeutics and Covalon Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescita TherapeuticsN/AN/AN/A
Covalon TechnologiesN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Crescita Therapeutics and Covalon Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescita Therapeutics0000N/A
Covalon Technologies0000N/A

Summary

Crescita Therapeutics beats Covalon Technologies on 3 of the 5 factors compared between the two stocks.

Emerald Health Therapeutics (CVE:EMH) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Earnings and Valuation

This table compares Emerald Health Therapeutics and Crescita Therapeutics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Emerald Health TherapeuticsC$13.02 million3.94C$-142,699,488.00C($0.70)-0.36
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00

Crescita Therapeutics has higher revenue and earnings than Emerald Health Therapeutics. Emerald Health Therapeutics is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Emerald Health Therapeutics and Crescita Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Emerald Health TherapeuticsN/AN/AN/A
Crescita TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Emerald Health Therapeutics and Crescita Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emerald Health Therapeutics0000N/A
Crescita Therapeutics0000N/A

Summary

Crescita Therapeutics beats Emerald Health Therapeutics on 4 of the 5 factors compared between the two stocks.

IntelGenx Technologies (CVE:IGX) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Earnings and Valuation

This table compares IntelGenx Technologies and Crescita Therapeutics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IntelGenx TechnologiesC$1.54 million38.41C$-9,064,710.00C($0.08)-6.54
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00

Crescita Therapeutics has higher revenue and earnings than IntelGenx Technologies. IntelGenx Technologies is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IntelGenx Technologies and Crescita Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
IntelGenx TechnologiesN/AN/AN/A
Crescita TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for IntelGenx Technologies and Crescita Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
IntelGenx Technologies0000N/A
Crescita Therapeutics0000N/A

Summary

Crescita Therapeutics beats IntelGenx Technologies on 4 of the 5 factors compared between the two stocks.

Quest PharmaTech (CVE:QPT) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Earnings and Valuation

This table compares Quest PharmaTech and Crescita Therapeutics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest PharmaTechC$38,871.00453.13C$109.88 millionC$0.660.16
Crescita TherapeuticsC$15.64 million1.06C$41,296.00C$0.00400.00

Quest PharmaTech has higher earnings, but lower revenue than Crescita Therapeutics. Quest PharmaTech is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Quest PharmaTech and Crescita Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Quest PharmaTechN/AN/AN/A
Crescita TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Quest PharmaTech and Crescita Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Quest PharmaTech0000N/A
Crescita Therapeutics0000N/A

Summary

Quest PharmaTech beats Crescita Therapeutics on 3 of the 5 factors compared between the two stocks.


Crescita Therapeutics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
SBM
Sirona Biochem
0.5$0.36-4.2%C$58.80 millionC$123,870.00-27.69
PMN
ProMIS Neurosciences
0.5$0.18-0.0%C$55.07 millionC$1,787.00-9.00News Coverage
Gap Down
COV
Covalon Technologies
0.6$1.55-3.2%C$37.44 millionC$23.84 million-6.51
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.25-2.0%C$34.02 millionC$13.02 million-0.36
IGX
IntelGenx Technologies
0.9$0.53-1.9%C$30.87 millionC$1.54 million-6.54
QPT
Quest PharmaTech
0.8$0.11-4.8%C$21.76 millionC$38,871.000.16High Trading Volume
Gap Up
CZO
Ceapro
0.7$0.72-2.8%C$21.65 millionC$16.14 million21.82
KNE
Kane Biotech
0.4$0.20-2.6%C$14.12 millionC$1.34 million-5.57High Trading Volume
GSD
Devonian Health Group
0.5$0.28-7.1%C$13.96 millionC$1.59 million-5.83Gap Down
PAS
Pascal Biosciences
0.6$0.08-6.3%C$12.70 millionN/A-3.64Gap Up
NSP
Naturally Splendid Enterprises
0.6$0.06-0.0%C$11.06 millionC$2.03 million-1.40
MPH
Medicure
0.7$1.63-1.2%C$10.80 millionC$12.71 million-1.05Gap Up
BTI
Bioasis Technologies
0.7$0.33-3.0%C$10.16 millionC$4.12 million30.00Gap Down
HEM
Hemostemix
0.6$0.34-1.5%C$9.07 millionN/A-2.02Gap Down
ICO
iCo Therapeutics
0.5$0.11-0.0%C$7.69 millionN/A-8.75
IBT
IBEX Technologies
0.7$0.38-2.6%C$6.94 millionC$5.60 million7.04
IOT
Innovotech
0.8$0.17-5.9%C$6.52 millionC$1.04 million85.00Gap Down
BCT
BriaCell Therapeutics
0.5$3.69-3.5%C$4.48 millionN/A-1.19
RVV
Revive Therapeutics
0.5$0.08-12.5%C$3.62 millionN/A-3.64High Trading Volume
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04-71.4%C$1.54 millionN/A-0.30Upcoming Earnings
Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03-16.7%C$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01-0.0%C$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
HALO
Halozyme Therapeutics
1.3$46.83-1.6%C$0.00C$267.59 million51.46
LTY
Liberty Biopharma
0.6$2.00-100.0%C$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49-6.3%C$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32-5.3%C$0.00N/A0.00News Coverage
Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.